Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Dietary Fiber × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Plasma cell 1

Conditions

Smoldering Multiple Myeloma 1

Interventions

Dexamethasone 861 Lenalidomide 453 Bortezomib 450 Cyclophosphamide 364 Melphalan 269 Calcium Dobesilate 261 daratumumab 231 pomalidomide 202 carfilzomib 180 fludarabine phosphate 139 fludarabine 136 Thalidomide 125 Peripheral Blood Stem Cell Transplantation 119 Filgrastim 114 ixazomib 93 Mycophenolic Acid 90 Granulocyte Colony-Stimulating Factor 89 Whole-Body Irradiation 87 Busulfan 87 dexamethasone acetate 85 Tacrolimus 78 dexamethasone 21-phosphate 73 Cyclosporine 68 auricularum 66 isatuximab 65 Prednisone 65 elotuzumab 57 Antilymphocyte Serum 56 belantamab mafodotin 55 Etoposide 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07069751 2026-04-03

HiFi-MM

IRCCS San Raffaele

Phase NA Recruiting

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡